These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 23937983)
1. Evaluation of 99mTc-probestin for imaging APN expressing tumors by SPECT. Pathuri G; Hedrick AF; Awasthi V; Ihnat MA; Gali H Bioorg Med Chem Lett; 2013 Sep; 23(18):5049-52. PubMed ID: 23937983 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo. Pathuri G; Hedrick AF; Disch BC; Doan JT; Ihnat MA; Awasthi V; Gali H Bioconjug Chem; 2012 Jan; 23(1):115-24. PubMed ID: 22148582 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biodistribution studies of technetium-99m-labeled aminopeptidase N inhibitor conjugates. Pathuri G; Hedrick AF; Disch BC; Ihnat MA; Awasthi V; Gali H Bioorg Med Chem Lett; 2012 Jul; 22(14):4567-70. PubMed ID: 22727671 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. Pathuri G; Madka V; Hedrick AF; Lightfoot SA; Awasthi V; Cowley BD; Rao CV; Gali H Mol Pharm; 2014 Aug; 11(8):2948-53. PubMed ID: 24988047 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT. Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel Tc-99m labeled NGR-containing hexapeptides as tumor imaging agents. Kim DW; Kim WH; Kim MH; Kim CG J Labelled Comp Radiopharm; 2015 Feb; 58(2):30-5. PubMed ID: 25583160 [TBL] [Abstract][Full Text] [Related]
8. Cerenkov luminescence tomography of aminopeptidase N (APN/CD13) expression in mice bearing HT1080 tumors. Hu Z; Yang W; Ma X; Ma W; Qu X; Liang J; Wang J; Tian J Mol Imaging; 2013 May; 12(3):173-81. PubMed ID: 23490443 [TBL] [Abstract][Full Text] [Related]
9. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression. Jia B; Shi J; Yang Z; Xu B; Liu Z; Zhao H; Liu S; Wang F Bioconjug Chem; 2006; 17(4):1069-76. PubMed ID: 16848417 [TBL] [Abstract][Full Text] [Related]
10. (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors. Tran T; Engfeldt T; Orlova A; Sandström M; Feldwisch J; Abrahmsén L; Wennborg A; Tolmachev V; Karlström AE Bioconjug Chem; 2007; 18(6):1956-64. PubMed ID: 17944527 [TBL] [Abstract][Full Text] [Related]
11. APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. Dunne M; Zheng J; Rosenblat J; Jaffray DA; Allen C J Control Release; 2011 Sep; 154(3):298-305. PubMed ID: 21640146 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates. Zhang Y; Sun Y; Xu X; Zhang X; Zhu H; Huang L; Qi Y; Shen YM J Med Chem; 2010 Apr; 53(8):3262-72. PubMed ID: 20350006 [TBL] [Abstract][Full Text] [Related]
13. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo. Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036 [TBL] [Abstract][Full Text] [Related]
14. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13). Cui SX; Zhang HL; Xu WF; Qu XJ Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845 [TBL] [Abstract][Full Text] [Related]
15. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model. Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387 [TBL] [Abstract][Full Text] [Related]
16. Novel Tc-99m labeled ELR-containing 6-mer peptides for tumor imaging in epidermoid carcinoma xenografts model: a pilot study. Kim DW; Kim WH; Kim MH; Kim CG Ann Nucl Med; 2013 Dec; 27(10):892-7. PubMed ID: 23990397 [TBL] [Abstract][Full Text] [Related]
17. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator. Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936 [TBL] [Abstract][Full Text] [Related]
18. Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer. Vaneycken I; Devoogdt N; Van Gassen N; Vincke C; Xavier C; Wernery U; Muyldermans S; Lahoutte T; Caveliers V FASEB J; 2011 Jul; 25(7):2433-46. PubMed ID: 21478264 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403 [TBL] [Abstract][Full Text] [Related]